Hostname: page-component-76d6cb85b7-dqfph Total loading time: 0 Render date: 2026-07-14T17:12:36.081Z Has data issue: false hasContentIssue false

Antimicrobial susceptibility patterns of Escherichia coli from various clinical sources

Published online by Cambridge University Press:  15 August 2025

Waleed A. Al Qahtani
Affiliation:
Laboratory Department, Armed Force Hospital, Jazan, Kingdom of Saudi Arabia
Mohamed S. Zaghlol*
Affiliation:
Department of Clinical Pathology, Faculty of Medicine, Al-Azhar University, Assiut, Egypt
Yazeed Ali Mohammed Qasem
Affiliation:
Laboratory Department, Armed Force Hospital, Jazan, Kingdom of Saudi Arabia
Mohsen M. Mashi
Affiliation:
Laboratory Department, Armed Force Hospital, Jazan, Kingdom of Saudi Arabia
Ahmed A. Daghriri
Affiliation:
Laboratory Department, Armed Force Hospital, Jazan, Kingdom of Saudi Arabia
Yahya kubaysi
Affiliation:
Laboratory Department, Armed Force Hospital, Jazan, Kingdom of Saudi Arabia
Hisham N. Hakami
Affiliation:
Laboratory Department, Armed Force Hospital, Jazan, Kingdom of Saudi Arabia
Alallah F. Khawaji
Affiliation:
Laboratory Department, Armed Force Hospital, Jazan, Kingdom of Saudi Arabia
Nabil T. Hakami
Affiliation:
Laboratory Department, Armed Force Hospital, Jazan, Kingdom of Saudi Arabia
Mohammed A. Jeraiby
Affiliation:
Basic Medical Science, faculty of medicine, Jazan University, Jazan, Kingdom of Saudi Arabia
Hassan N. Moafa
Affiliation:
Department of Public Health, College of Nursing and Health Sciences, Jazan University, Jazan, Kingdom of Saudi Arabia
Mohammed Ezzi
Affiliation:
Department of Surgery, Faculty of Medicine, Jazan University, Jazan, Kingdom of Saudi Arabia
Jobran M Moshi
Affiliation:
Department of Medical Laboratory Technology, College of Nursing and Health Science, Jazan University, Jazan, Kingdom of Saudi Arabia. Health Research Centre, Jazan University, Jazan, Kingdom of Saudi Arabia
*
Corresponding author: Mohamed S. Zaghlol; Email: zaghlol_msz@yahoo.com

Abstract

Background:

Escherichia coli, frequently abbreviated as E. coli, is a common gastrointestinal tract inhabitant in both people and animals. It may also be found in soil, aquatic settings, and plants.

Aim:

The purpose of the study was to identify the frequency and three susceptibilities of E. coli in various clinical samples taken from patients in the Jazan area.

Materials and methods:

Using a multi-center approach, this retrospective cross-sectional study analyzed the results of culture and antimicrobial susceptibility of isolates from urine, wound swabs, and sputum samples. The study covered the period from January 2023 to December 2023 and included all public and private hospitals in the Jazan region.

Results:

The majority of isolates were derived from urine samples in 1161 patients (85.49%), followed by pus in 123 patients (9.06%) and sputum in 74 patients (5.45%). There were high sensitivity rates to Amikacin, Tigecycline, and Imipenem by (97.49%), (90.87%), and (90.35%), respectively, while there were high resistance rates to Norfloxacin, Ampicillin, and Cefotaxime by (93.67%), (79.60%), and (71.65%), respectively.

Conclusion:

There was considerable resistance to commonly used antibiotics among Escherichia coli germs isolated from several clinical specimens. Antibiotics, including imipenem, amikacin, and nitrofurantoin, demonstrated the highest efficacy against E. coli isolates. Nalidixic acid, cefexime, and ceftriaxone showed efficacy against E. coli; nevertheless, several clinical isolates exhibited resistance.

Information

Type
Original Article
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2025. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America
Figure 0

Figure 1. Shows distribution of positive culture isolates.

Figure 1

Figure 2. Shows distribution of specimen in studied group.

Figure 2

Figure 3. Shows distribution of antimicrobial susceptibility pattern of E. coli isolates.

Figure 3

Figure 4. Shows distribution of antimicrobial susceptibility pattern of E. coli isolates.

Figure 4

Table 1. Distribution of positive culture isolates in all studied patients

Figure 5

Table 2. Distribution of demographic data in patients with positive culture E. coli

Figure 6

Table 3. Distribution of specimens in patients with positive culture of E. coli

Figure 7

Table 4. E. coli isolates’ responsiveness to various antibiotics